SEC Form 4 · accession 0001553878-18-000020
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Schimmel
Director
Period of report
Mar 13, 2018
Accepted (ET)
Mar 14, 2018 · 7:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 13, 2018 | M | 10,000 | $30.09 | A | 10,000 | D | |
| Common Stock | Mar 13, 2018 | M | 2,823 | $63.86 | A | 12,823 | D | |
| Common Stock | Mar 13, 2018 | M | 15,000 | $59.25 | A | 27,823 | D | |
| Common Stock | Mar 13, 2018 | S | 27,823 | $150.00 | D | 0 | D | |
| Common StockF2 | holding | — | — | — | 306,996 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $59.25 | Mar 13, 2018 | M | 15,000 | D | Jun 5, 2015 | Jun 4, 2024 | Common Stock | 15,000 | 0 | D |
| Stock Option (right to buy)F3 | $63.86 | Mar 13, 2018 | M | 2,823 | D | Mar 31, 2014 | Jan 2, 2024 | Common Stock | 2,823 | 0 | D |
| Stock Option (right to buy) | $30.09 | Mar 13, 2018 | M | 10,000 | D | Jun 6, 2014 | Jun 6, 2023 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 23, 2017.
- F2The Paul Schimmel Prototype PSP has holdings of 188,601 shares and the reporting person is trustee. The Schimmel Revocable Trust U/A dated 9/6/2000 has holdings of 118,395 shares and the reporting person and his spouse are trustees.
- F3The stock option vests as to 25% on 3/31/2014 and as to an additional 25% of the shares granted at the end of each subsequent quarter.